Unicorn Capital Partners logo

Unicorn Capital Partners

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Unicorn Capital Partners is an early stage venture capital fund-of-funds and direct investment platform focused on China and Asia

Investor Profile

Unicorn Capital Partners has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Series C (40%)
  • Series A (20%)
  • Series B (20%)
  • Series Unknown (20%)

Country Focus

  • China (80%)
  • United States (20%)

Industry Focus

  • Enterprise
  • Artificial Intelligence (Ai)
  • Construction
  • Internet Of Things
  • Robotics
  • Biotechnology
  • Life Science
  • Pharmaceutical
  • Information Technology
  • Saas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Unicorn Capital Partners frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Xiamen C&D Corporation
Asia, Fujian, China, Xiamen
Co-Investments: 1
HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
Linear Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Boyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Unicorn Capital Partners?

Weijian Technology

Baoshan, Shanghai, China

Weijian Technology is a building intelligent robotics product company for the construction industry through robots, IoT, and AI algorithms.

Artificial Intelligence (AI)ConstructionInternet of ThingsRobotics
Series AAug 23, 2024
Amount Raised: $16,846,598
ArriVent Biopharma

Pennsylvania Furnace, Pennsylvania, United States

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

BiotechnologyLife SciencePharmaceutical
Series BDec 29, 2022
Amount Raised: $155,000,000
Guandata

Hangzhou, Zhejiang, China

Guandata is committed to providing next-generation data analytics and business intelligence (BI) solutions.

AnalyticsEnterprise
Series CFeb 22, 2022
Amount Raised: $44,258,978
ZhenYun Information Technology

Shanghai, Shanghai, China

Going-Link is an Enterprise services company.

EnterpriseInformation TechnologySaaSSoftware
Series CNov 26, 2021
Amount Raised: $101,673,706
Duckbill

Shanghai, Shanghai, China

Duckbill is a logistics startup that provides container trucking transportation services.

Freight ServiceLogisticsTransportation
Series UnknownMar 17, 2021
Amount Raised: $50,000,000